MFA Wealth Services’s Quest Diagnostics DGX Stock Holding History

MFA Wealth Services’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Buy	+945	New	+$185K	0.12%	133

Other funds holding DGX

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

MFA Wealth Services's DGX Position: Q2 2026 in Review

MFA Wealth Services opened a new position in Quest Diagnostics (DGX) in Q2 2026: 945 shares worth $200K. The stake represents 0.12% of the portfolio and ranks #133 among its holdings.

232 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

MFA Wealth Services held 945 shares of Quest Diagnostics worth $200K as of Q2 2026.
Quest Diagnostics was a new MFA Wealth Services position in Q2 2026.
Quest Diagnostics made up 0.12% of MFA Wealth Services's portfolio in Q2 2026, its #133 holding.
232 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MFA Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.